Financhill
Back

Myriad Genetics Vs. ResMed Industry Stock Comparison

Sell
16

MYGN
Myriad Genetics

Last Price:
15.00
Seasonality Move:
18.24%
Sell
49

RMD
ResMed

Last Price:
242.90
Seasonality Move:
9.06%
Sell
16
Myriad Genetics (MYGN) is a Sell

Is Myriad Genetics a Buy, Sell or Hold?

  • The current Myriad Genetics [MYGN] share price is $15.30. The Score for MYGN is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • MYGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
ResMed (RMD) is a Sell

Is ResMed a Buy, Sell or Hold?

  • The current ResMed [RMD] share price is $241.55. The Score for RMD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MYGN Stock Price Chart

What is Myriad Genetics's stock price today?

  • The Myriad Genetics share price today is $15.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RMD Stock Price Chart

What is ResMed's stock price today?

  • The ResMed share price today is $241.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RMD is experiencing buying pressure, which is a positive indicator for future bullish movement.

MYGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.29 Sell
Relative Strength Index (14 RSI): 19.49 Sell
Chaikin Money Flow: 619490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.08 - 22.24) Sell
Bollinger Bands (100): (21.09 - 28.73) Sell

RMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 50.05 Buy
Chaikin Money Flow: 373532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (237.06 - 248.1) Sell
Bollinger Bands (100): (211.52 - 248.06) Buy

MYGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.71 Sell
20-day SMA: 18.2 Sell
50-day SMA: 22.79 Sell
200-day SMA: 23.48 Sell
8-day EMA: 15.86 Sell
20-day EMA: 17.95 Sell
50-day EMA: 21.27 Sell
200-day EMA: 22.98 Sell

RMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 239.58 Buy
20-day SMA: 243.43 Sell
50-day SMA: 242.38 Sell
200-day SMA: 213.27 Buy
8-day EMA: 240.02 Buy
20-day EMA: 241.47 Buy
50-day EMA: 239.48 Buy
200-day EMA: 218.35 Buy

Myriad Genetics Earnings Growth & MYGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.00 per share.

ResMed Earnings Growth & RMD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $1.69 per share.

Myriad Genetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ResMed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):